Ligand profile
DKZ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00667 — Glycogen phosphorylase
Identifiers
Database identifiers and provenance.
- Ligand ID
DKZ- PDB
3l7b- UniProt (similar protein)
P00489- Target protein
- KP13_00667
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 130.8
- −1 ≤ LogP ≤ 5 -2.22
- MW ≤ 500 Da 275.2
- LogP ≤ 5 -2.22
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 130.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)F)OC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)F)O
InChI=1S/C10H14FN3O5/c11-6-7(16)4(3-15)19-9(8(6)17)14-2-1-5(12)13-10(14)18/h1-2,4,6-9,15-17H,3H2,(H2,12,13,18)/t4-,6+,7-,8-,9-/m1/s1InChI=1S/C10H14FN3O5/c11-6-7(16)4(3-15)19-9(8(6)17)14-2-1-5(12)13-10(14)18/h1-2,4,6-9,15-17H,3H2,(H2,12,13,18)/t4-,6+,7-,8-,9-/m1/s1
AGFREDUIXIMAKC-PMPOVCSBSA-NAGFREDUIXIMAKC-PMPOVCSBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00343
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand DKZ →
- PDB RCSB structure 3l7b →
- UniProt UniProt P00489 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “DKZ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00667.
PDB 115
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).